Studies should also distinguish between surrogate outcomes and clinical outcomes
This is called metabolic adaptation
The specialty pharmacy component, Accredo, generates revenue from manufacturers through both dispensing fees and data licensing arrangements a secondary IP monetization stream that blurs the line between service provider and market intelligence vendor
Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
Also, assess weight changes and symptoms related to GI side effects, which are common in the first few months
For overall recovery including body composition goals, GH or GH secretagogues might be considered